Shopping Cart 0
Cart Subtotal
USD 0

Mayo Foundation for Medical Education and Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Mayo Foundation for Medical Education and Research (Mayo) is a non-profit organization that provides healthcare for complex conditions through its Mayo Clinics. Mayo operates a network of hospitals, clinics and health care facilities, serving communities in Minnesota, Iowa, Georgia and Wisconsin. It also conducts research and trainings for physicians, nurses, and other health professionals. Its services include heart care, transplantation, cancer treatment, neurosciences and medical research. The foundation provides its products and services to consumer, business and professionals. Mayo's research clinics include Cancer Center, Center for Translational Science Activities (CTSA), Institutional Review Board, Clinical Trials and Research Fellow's Association. Mayo is headquartered in Rochester Minnesota, the US.

Mayo Foundation for Medical Education and Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deal Details 14

Venture Financing 14

Qrativ Raises USD8.3 Million in Series A Financing 14

Evelo Biosciences Raises USD50 Million in Series B Financing 14

DayTwo Secures USD12 Million in Series A Funding 16

DayTwo Raises USD12 Million in Series A Financing 17

Second Genome Raises USD42.6 Million in Series B Financing 18

Unity Biotechnology Raises Funds in Venture Financing 19

AssureRx Health Raises Additional USD15 Million in Series D Financing 20

OxThera Raises USD10.7 Million In Venture Financing 21

Partnerships 22

Mayo Clinic and nference Form Joint Venture 22

Baxter International and Mayo Clinic Enter into Research Agreement 23

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23

EnBiotix Partners with Mayo Clinic 24

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25

GE Ventures Forms Joint Venture with Mayo Clinic 26

Morphotek Enters into Agreement with Mayo Clinic 27

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28

Seres Health Enters into Research Agreement with Mayo Clinic 29

Licensing Agreements 29

Mayo Clinic Enters into Licensing Agreement with ID Pharma 29

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35

Acquisition 36

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36

Mayo Foundation for Medical Education and Research-Key Competitors 38

Key Employees 39

Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Recent Developments 41

Government and Public Interest 41

Feb 11, 2016: Long-term benefits of 'senolytic' drugs on vascular health in mice 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10


List Of Table

List of Tables

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Key Facts 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Qrativ Raises USD8.3 Million in Series A Financing 14

Evelo Biosciences Raises USD50 Million in Series B Financing 14

DayTwo Secures USD12 Million in Series A Funding 16

DayTwo Raises USD12 Million in Series A Financing 17

Second Genome Raises USD42.6 Million in Series B Financing 18

Unity Biotechnology Raises Funds in Venture Financing 19

AssureRx Health Raises Additional USD15 Million in Series D Financing 20

OxThera Raises USD10.7 Million In Venture Financing 21

Mayo Clinic and nference Form Joint Venture 22

Baxter International and Mayo Clinic Enter into Research Agreement 23

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23

EnBiotix Partners with Mayo Clinic 24

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25

GE Ventures Forms Joint Venture with Mayo Clinic 26

Morphotek Enters into Agreement with Mayo Clinic 27

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28

Seres Health Enters into Research Agreement with Mayo Clinic 29

Mayo Clinic Enters into Licensing Agreement with ID Pharma 29

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36

Mayo Foundation for Medical Education and Research, Key Competitors 38

Mayo Foundation for Medical Education and Research, Key Employees 39

Mayo Foundation for Medical Education and Research, Subsidiaries 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Mayo Foundation for Medical Education and Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Mayo Foundation for Medical Education and Research (Mayo) is a non-profit organization that provides healthcare for complex conditions through its Mayo Clinics. Mayo operates a network of hospitals, clinics and health care facilities, serving communities in Minnesota, Iowa, Georgia and Wisconsin. It also conducts research and trainings for physicians, nurses, and other health professionals. Its services include heart care, transplantation, cancer treatment, neurosciences and medical research. The foundation provides its products and services to consumer, business and professionals. Mayo's research clinics include Cancer Center, Center for Translational Science Activities (CTSA), Institutional Review Board, Clinical Trials and Research Fellow's Association. Mayo is headquartered in Rochester Minnesota, the US.

Mayo Foundation for Medical Education and Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deal Details 14

Venture Financing 14

Qrativ Raises USD8.3 Million in Series A Financing 14

Evelo Biosciences Raises USD50 Million in Series B Financing 14

DayTwo Secures USD12 Million in Series A Funding 16

DayTwo Raises USD12 Million in Series A Financing 17

Second Genome Raises USD42.6 Million in Series B Financing 18

Unity Biotechnology Raises Funds in Venture Financing 19

AssureRx Health Raises Additional USD15 Million in Series D Financing 20

OxThera Raises USD10.7 Million In Venture Financing 21

Partnerships 22

Mayo Clinic and nference Form Joint Venture 22

Baxter International and Mayo Clinic Enter into Research Agreement 23

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23

EnBiotix Partners with Mayo Clinic 24

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25

GE Ventures Forms Joint Venture with Mayo Clinic 26

Morphotek Enters into Agreement with Mayo Clinic 27

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28

Seres Health Enters into Research Agreement with Mayo Clinic 29

Licensing Agreements 29

Mayo Clinic Enters into Licensing Agreement with ID Pharma 29

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35

Acquisition 36

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36

Mayo Foundation for Medical Education and Research-Key Competitors 38

Key Employees 39

Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Recent Developments 41

Government and Public Interest 41

Feb 11, 2016: Long-term benefits of 'senolytic' drugs on vascular health in mice 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10


List Of Table

List of Tables

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Key Facts 1

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017 9

Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10

Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Qrativ Raises USD8.3 Million in Series A Financing 14

Evelo Biosciences Raises USD50 Million in Series B Financing 14

DayTwo Secures USD12 Million in Series A Funding 16

DayTwo Raises USD12 Million in Series A Financing 17

Second Genome Raises USD42.6 Million in Series B Financing 18

Unity Biotechnology Raises Funds in Venture Financing 19

AssureRx Health Raises Additional USD15 Million in Series D Financing 20

OxThera Raises USD10.7 Million In Venture Financing 21

Mayo Clinic and nference Form Joint Venture 22

Baxter International and Mayo Clinic Enter into Research Agreement 23

Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23

EnBiotix Partners with Mayo Clinic 24

Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25

Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25

GE Ventures Forms Joint Venture with Mayo Clinic 26

Morphotek Enters into Agreement with Mayo Clinic 27

Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28

Seres Health Enters into Research Agreement with Mayo Clinic 29

Mayo Clinic Enters into Licensing Agreement with ID Pharma 29

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30

Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31

PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32

WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33

Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34

Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35

TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35

Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36

Mayo Foundation for Medical Education and Research, Key Competitors 38

Mayo Foundation for Medical Education and Research, Key Employees 39

Mayo Foundation for Medical Education and Research, Subsidiaries 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Mayo Foundation for Medical Education and Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.